Why grow brain models in space?

Brain organoids let scientists probe aspects of brain biology that would be difficult or impossible to study in living people. Researchers hope the station-based experiments will reveal potential targets for treating neurological conditions, including Alzheimer's disease, Parkinson's disease and multiple sclerosis.

The results are preliminary by definition — these are experiments, not treatments. But the work points at a practical goal: finding biological targets that future drugs could act on.

That's the payoff researchers are chasing.

Could space-built retinas restore vision?

The mission also delivered equipment for manufacturing artificial retinas in microgravity. NASA says producing these structures in the near-weightless environment of orbit could eventually lead to technologies that restore vision for people on Earth.

The emphasis is on "eventually." The station experiments are an early step, and any clinical application would require years of follow-up research and testing.

Still, the logic is straightforward. If microgravity lets retinal structures form more cleanly than they do on the ground, orbit becomes a factory floor for something medicine has struggled to build.

When did the mission start, and what happens next?

The flight began on October 13 at 6:33 a.m. EDT, when a SpaceX Falcon 9 rocket lifted off from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida.

Dragon will stay docked at the space-facing port of the station's Harmony module until mid-November. It will then return to Earth loaded with time-sensitive research materials and other cargo, ending its trip with a splashdown in the Pacific Ocean off the California coast.

The quick turnaround matters. Some experiments can't wait weeks for a ride home, and the returning samples will feed directly into laboratory analysis.

For now, the station's crew has unpacking to do — and science that could eventually reach hospital wards back on Earth.